Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | LALPATHLAB Dr. Lal Path Labs Ltd. Pharma · Small | PPLPHARMA Piramal Pharma Limited Pharma · Small | PINELABS Pine Labs Limited Pharma · Small | NATCOPHARM Natco Pharma Limited Pharma · Small |
|---|---|---|---|---|
| Final Score | 49 | 24 | 32 | 79 |
| Verdict | FAIR VALUE | OVERVALUED | WATCHLIST | DEEP VALUE |
| Style | Premium Compounder | OVERVALUED | WATCHLIST | Top Setup |
| Piotroski | 8/9 | 5/9 | 8/9 | 8/9 |
| Valuation | 0/30 | 5/30 | 2/30 | 26/30 |
| Growth | 15/25 | 3/25 | 15/25 | 23/25 |
| Quality | 15/20 | 0/20 | 0/20 | 8/20 |
| Balance Sheet | 10/15 | 6/15 | 8/15 | 12/15 |
| Cash Flow | 4/10 | 7/10 | 1/10 | 4/10 |
| Price | ₹1,565 | ₹168.87 | ₹152.36 | ₹867.9 |
| P/E | 49.20 | — | 143.00 | 11.00 |
| P/B | 10.31 | 2.69 | 2.79 | 1.69 |
| ROE | 22.50% | -3.58% | 2.46% | 16.90% |
| ROCE | 28.30% | 2.69% | 4.16% | 17.10% |
| Debt / Equity | 0.08 | 0.70 | 0.07 | 0.08 |
| FCF Yield | 0.83% | 3.76% | — | — |
| Dividend Y | 0.91% | 0.08% | — | 0.69% |
| Altman Z | 9.03 | 2.71 | 2.39 | 7.29 |
| Promoter % | 53.21% | 34.85% | — | 49.41% |
| Mkt Cap (₹Cr) | 25931.00 | 22013.00 | 16400.00 | 15548.00 |
| Graham # | ₹318.89 | — | ₹33.63 | ₹957.98 |
| Fair PE | 42.0 | 0.7 | 42.0 | 42.0 |
| MoS % | -23.7% | — | -270.2% | +73.9% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startLALPATHLAB51
PPLPHARMA60
PINELABS61
NATCOPHARM137